Allianz Asset Management Gmb H Igm Biosciences, Inc. Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$27.59 - $66.39 $395,226 - $951,036	-14,325 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$65.76 - $90.65 $164,400 - $226,625	2,500 Added 21.14%	14,325 $942,000
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $115,960 - $193,200	-2,000 Reduced 14.47%	11,825 $984,000
Q1 2021 May 13, 2021	BUY	$71.56 - $121.23 $989,317 - $1.68 Million	13,825 New	13,825 $1.06 Million
Q3 2020 Nov 13, 2020	SELL	$43.0 - $84.01 $628,144 - $1.23 Million	-14,608 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $749,390 - $1.1 Million	14,608 New	14,608 $1.07 Million

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $60.5M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.